These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35946480)

  • 61. One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature.
    Yakubov R; Ayman A; Kremer AK; van den Akker M
    J Med Case Rep; 2019 Dec; 13(1):386. PubMed ID: 31883531
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Familial pseudohypoaldosteronism: a review on the heterogeneity of the syndrome.
    Kuhnle U; Hinkel GK; Akkurt HI; Krozowski Z
    Steroids; 1995 Jan; 60(1):157-60. PubMed ID: 7792804
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pseudohypoaldosteronism type I].
    Kaneko K
    Nihon Jinzo Gakkai Shi; 2011; 53(2):150-4. PubMed ID: 21516697
    [No Abstract]   [Full Text] [Related]  

  • 64. Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor.
    Komesaroff PA; Verity K; Fuller PJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):27-31. PubMed ID: 8027241
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3'-end processing.
    Saoura M; Powell CA; Kopajtich R; Alahmad A; Al-Balool HH; Albash B; Alfadhel M; Alston CL; Bertini E; Bonnen PE; Bratkovic D; Carrozzo R; Donati MA; Di Nottia M; Ghezzi D; Goldstein A; Haan E; Horvath R; Hughes J; Invernizzi F; Lamantea E; Lucas B; Pinnock KG; Pujantell M; Rahman S; Rebelo-Guiomar P; Santra S; Verrigni D; McFarland R; Prokisch H; Taylor RW; Levinger L; Minczuk M
    Hum Mutat; 2019 Oct; 40(10):1731-1748. PubMed ID: 31045291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.
    Jeong HA; Park YK; Jung YS; Nam MH; Nam HK; Lee KH; Rhie YJ
    Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):230-4. PubMed ID: 26817011
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.
    Dirlewanger M; Huser D; Zennaro MC; Girardin E; Schild L; Schwitzgebel VM
    Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E467-73. PubMed ID: 21653223
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exclusion of the locus for autosomal recessive pseudohypoaldosteronism type 1 from the mineralocorticoid receptor gene region on human chromosome 4q by linkage analysis.
    Chung E; Hanukoglu A; Rees M; Thompson R; Dillon M; Hanukoglu I; Bistritzer T; Kuhnle U; Seckl J; Gardiner RM
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3341-5. PubMed ID: 7593448
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Phenotype and Outcome of Infantile Cardiomyopathy Caused by a Homozygous ELAC2 Mutation.
    Shinwari ZMA; Almesned A; Alakhfash A; Al-Rashdan AM; Faqeih E; Al-Humaidi Z; Alomrani A; Alghamdi M; Colak D; Alwadai A; Rababh M; Al-Fayyadh M; Al-Hassnan ZN
    Cardiology; 2017; 137(3):188-192. PubMed ID: 28441660
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation.
    Tanaka T; Oki E; Mori T; Tsuruga K; Sohara E; Uchida S; Tanaka H
    Nephrology (Carlton); 2019 Apr; 24(4):489-490. PubMed ID: 30919533
    [No Abstract]   [Full Text] [Related]  

  • 71. Pseudohypoaldosteronism type II: history, arguments, answers, and still some questions.
    Healy JK
    Hypertension; 2014 Apr; 63(4):648-54. PubMed ID: 24396028
    [No Abstract]   [Full Text] [Related]  

  • 72. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults.
    Geller DS; Zhang J; Zennaro MC; Vallo-Boado A; Rodriguez-Soriano J; Furu L; Haws R; Metzger D; Botelho B; Karaviti L; Haqq AM; Corey H; Janssens S; Corvol P; Lifton RP
    J Am Soc Nephrol; 2006 May; 17(5):1429-36. PubMed ID: 16611713
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Syndromes of impaired ion handling in the distal nephron: pseudohypoaldosteronism and familial hyperkalemic hypertension.
    Kostakis ID; Cholidou KG; Perrea D
    Hormones (Athens); 2012; 11(1):31-53. PubMed ID: 22450343
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism.
    Bistritzer T; Kerem E; Berkovitch M; Rapoport MJ; Evans S; Aladjem M
    Clin Endocrinol (Oxf); 2002 May; 56(5):575-80. PubMed ID: 12030906
    [TBL] [Abstract][Full Text] [Related]  

  • 75. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism.
    Arai K; Tsigos C; Suzuki Y; Listwak S; Zachman K; Zangeneh F; Rapaport R; Chanoine JP; Chrousos GP
    J Clin Endocrinol Metab; 1995 Mar; 80(3):814-7. PubMed ID: 7883835
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical features and molecular basis of pseudohypoaldosteronism type 1.
    Tajima T; Morikawa S; Nakamura A
    Clin Pediatr Endocrinol; 2017; 26(3):109-117. PubMed ID: 28804203
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.
    Canonica J; Sergi C; Maillard M; Klusonova P; Odermatt A; Koesters R; Loffing-Cueni D; Loffing J; Rossier B; Frateschi S; Hummler E
    Pflugers Arch; 2016 May; 468(5):895-908. PubMed ID: 26762397
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes.
    Hanukoglu A; Edelheit O; Shriki Y; Gizewska M; Dascal N; Hanukoglu I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):268-74. PubMed ID: 18634878
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The enigma of pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Soubrier F; Armanini D; Corvol P
    Steroids; 1994 Feb; 59(2):96-9. PubMed ID: 8191555
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
    Riepe FG; Holterhus PM
    Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.